PHARMACEUTICAL giant Pfizer will close its Thebarton manufacturing plant in Adelaide by the end of 2021, despite announcing plans to expand the site into a "state-of-the-art" facility less than 12 months ago, reports ABC News.
The Thebarton factory employs 89 workers and makes pegfilgrastim, used in chemotherapy treatment and exported globally.
Pfizer acquired the factory in 2015 and in Mar last year announced plans to expand the site at a cost of $21m, but now has announced the need to consolidate its global manufacturing capacity.
The above article was sent to subscribers in Pharmacy Daily's issue from 13 Feb 17
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 13 Feb 17
